31.07.2013 Views

2011 ADA Posters 1261-2041.indd - Diabetes

2011 ADA Posters 1261-2041.indd - Diabetes

2011 ADA Posters 1261-2041.indd - Diabetes

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Integrated Physiology/<br />

Obesity<br />

POSTERS<br />

prevented the THAP- and TUNI-induced decreases in insulin-stimulated<br />

IRS1 Y 612 phosphorylation and glucose uptake. These data suggest a novel<br />

paradigm where ER stress enhances TRB3 expression leading to insulin<br />

resistance in skeletal muscle. <strong>ADA</strong>-Funded Research<br />

& 1715-P<br />

Effects of Muscle Specifi c Deletion of Carnitine Palmitoyltransferase<br />

and Carnitine Acetyltransferase on Fuel Selection<br />

JINGYING ZHANG, ROBERT C. NOLAN, SARAH E. SEILER, TIMOTHY R. KOVES,<br />

INDU KHETERPAL, ROBERT D. STEVENS, OLGA R. ILKAYEVA, DEBORAH M.<br />

MUOIO, RANDALL L. MYNATT, Baton Rouge, LA, Durham, NC<br />

Mitochondrial fatty acid import and oxidation is initiated by carnitine<br />

palmitoyltransferase-I (CPTI). CPTI is located in the outer mitochondrial<br />

membrane and catalyzes the formation of long chain acyl-carnitines from<br />

carnitine and acyl-CoA. Short chain acyl-carnitines are formed via the<br />

activity of carnitine acetyltransferase (CrAT) in the mitochondrial matrix.<br />

Even though CrAT’s role is not completely understood, it is thought to buffer<br />

acetyl-CoA/CoA in the mitochondria. To understand the role of each enzyme<br />

in energy homeostasis, substrate utilization and insulin sensitivity; mice<br />

were generated with muscle specifi c deletion of CPT-I m-/- and CrAT m-/- . CPT-<br />

I m-/- and CrAT m-/- mice have normal body weight, fat mass, fat free mass,<br />

energy expenditure and food intake. However, long chain fatty acid oxidation<br />

is greatly reduced in muscle homogenates and isolated mitochondria<br />

from CPT-I m-/- mice. Given the popular hypothesis that impaired fatty acid<br />

oxidation in skeletal muscle causes the accumulation of lipid intermediates<br />

leading to insulin resistance, we paradoxically observed improved GTT<br />

and ITT in CPT-I m-/- mice relative to control mice. Metabolic chamber data<br />

demonstrated that CPT-I m-/- mice oxidize more carbohydrate than control<br />

mice. Conversely, CrAT m-/- mice had impaired GTT and ITT relative to control<br />

mice. Metabolic chamber data revealed no difference in 24 hour RER<br />

between CrAT m-/- and control mice, but there is impaired switching from<br />

fatty acid oxidation to carbohydrate oxidation during the transition from a<br />

fasted to fed state. In vitro studies in muscle homogenates and isolated<br />

mitochondria demonstrated that the addition of carnitine increased PDH<br />

activity and the complete oxidation of pyruvate in control mice but not CrAT<br />

m-/- mice. In addition, the ability of pyruvate to suppress fatty acid oxidation<br />

was blunted in mitochondria from CrAT m-/- mice. Together our data indicate<br />

that, the loss of skeletal muscle CPTI results in reduced oxidization of long<br />

chain fatty acids and stimulates glucose oxidation, whereas the loss of CrAT<br />

in muscle predominately affects metabolic fl exibility.<br />

Supported by: NIH <strong>ADA</strong>-Funded Research<br />

& 1716-P<br />

<strong>Diabetes</strong> Mellitus Impact on Left Ventricular Myocardial Structure<br />

and Function in Aortic Stenosis before Valve Replacement<br />

INÊS FALCÃO-PIRES, NAZHA HAMDANI, CRISTINA GAVINA, JOLANDA VAN DER<br />

VELDEN, ATTILA BORBÉLY, HANS NIESSEN, GER STIENEN, ADELINO F. LEITE-<br />

MOREIRA, WALTER J. PAULUS, Porto, Portugal, Amsterdam, The Netherlands,<br />

Debrecen, Hungary, Amsterdam, Portugal<br />

<strong>Diabetes</strong> mellitus (DM) is an independent risk factor for progression of<br />

aortic valve stenosis (AS) and signifi cantly impacts longterm outcome after<br />

valve replacement. High incidence of residual heart failure may account<br />

for this prognosis. We aimed to assess the impact of DM on diastolic (dys)<br />

function of AS patients.<br />

Patients with severe isolated AS (n=46) and AS plus type-II diabetes<br />

(AS-DM + ,n=16) with preserved left ventricular (LV) ejection fraction and<br />

no clinical or angiographic signs of coronary artery disease were studied.<br />

Doppler echocardiographic data was used to compare in vivo LV function.<br />

Biopsies were used to assess fi brosis, cardiomyocyte hypertrophy<br />

(MyD), advanced glycation endproducts (AGEs) and phosphorylation of<br />

myofi lamentary proteins. Isolated and permeabilized cardiomyocytes were<br />

used to measure active force (F active ), resting force (F passive ) and myofi lament<br />

calcium sensitivity(pCa 50 ).<br />

In isolated AS, LV deceleration time and end-diastolic pressure were<br />

augmented (239±19ms; 21.4±1.4mmHg, respectively) and the latter<br />

signifi cantly correlated with increased fi brosis (12.9±1.1%; r=0.40,p=0.04)<br />

and MyD (22.9±0.5μm; r=0.60, p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!